Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: A phase 2 dose-finding study - Heit, JA; Colwell, CW; Francis, CW; AstraZeneca Arthroplasty Study Group. (Arch Intern Med, 2001)